ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine

Circulation

Volumn 122, Issue 24, 2010, Pages 2583-2618

  Olin, Jeffrey W ^a   Allie, David E ^a   Belkin, Michael ^a   Bonow, Robert O ^a   Casey, Donald E ^a   Creager, Mark A ^a   Gerber, Thomas C ^a   Hirsch, Alan T ^a   Jaff, Michael R ^a   Kaufman, John A ^a   Lewis, Curtis A ^a   Martin, Edward T ^a   Martin, Louis G ^a   Sheehan, Peter ^a   Stewart, Kerry J ^a   Treat Jacobson, Diane ^a   White, Christopher J ^a   Zheng, Zhi Jie ^a   Masoudi, Frederick A ^a   Delong, Elizabeth ^a   Erwin, John P ^a   Goff, David C ^a   Grady, Kathleen ^a   Green, Lee A ^a   Heidenreich, Paul A ^a   Jenkins, Kathy J ^a   Loth, Ann R ^a   Peterson, Eric D ^a   Shahian, David M ^a   more..

^a NONE

Author keywords

abdominal aortic aneurysm; AHA Scientific Statements; ankle brachial index; peripheral arterial disease; secondary prevention; supervised exercise

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ABDOMINAL AORTA ANEURYSM; ACUTE DISEASE; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIABETES MELLITUS; EXERCISE; HUMAN; HYPERTENSION; KIDNEY ARTERY; LEG; LIMB ISCHEMIA; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL SOCIETY; MESENTERIC ARTERY; OUTCOME ASSESSMENT; PATIENT CARE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; REVASCULARIZATION; SCREENING; TREADMILL EXERCISE;

ADULT; ADVISORY COMMITTEES; AMERICAN HEART ASSOCIATION; CARDIOLOGY; CORONARY ANGIOGRAPHY; HUMANS; NURSING; PERIPHERAL ARTERIAL DISEASE; RADIOLOGY; SOCIETIES, MEDICAL; UNITED STATES; VASCULAR DISEASES;

EID: 78650719727     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0b013e3182031a3c     Document Type: Article

References (73)

1. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.
2. Bonow RO, Bennett S, Casey DE Jr., et al. ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures). J Am Coll Cardiol. 2005;46:1144-78.
3. American Medical Association Physician Consortium for Performance Improvement. Clinical performance measures: chronic stable coronary artery disease. Available at: http://www.ama-assn.org/ama1/pub/upload/ mm/370/cadminisetjune06.pdf. Accessed January 5, 2010.
4. American Medical Association Physician Consortium for Performance Improvement. Clinical performance measures: hypertension. Available at: http://www.ama-assn.org/ama1/pub/upload/mm/370/hypertension-8-05.pdf. Accessed January 5, 2010.
5. Krumholz HM, Anderson JL, Brooks NH, et al. ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol. 2006;47:236-65.
6. Krumholz HM, Anderson JL, Bachelder BL, et al. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myo-cardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol. 2008;52:2046-99.
7. Thomas RJ, King M, Lui K, et al. AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services. J Am Coll Cardiol. 2007;50:1400-33.
8. Thomas RJ, King M, Lui K, et al. AACVPR/ACCF/AHA 2010 update: performance measures on cardiac rehabilitation for referral to cardiac rehabilitation/ secondary prevention services. J Am Coll Cardiol. 2010; 56:1159-67.
9. Estes NA 3rd, Halperin JL, Calkins H, et al. ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonval-vular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation). J Am Coll Cardiol. 2008;51:865-84.
10. Redberg RF, Benjamin EJ, Bittner V, et al. ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease). J Am Coll Cardiol. 2009;54:1364-405.
11. Spertus JA, Eagle KA, Krumholz HM, et al. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. J Am Coll Cardiol. 2005;45:1147-56.
12. Krumholz HM, Brindis RG, Brush JE, et al. Standards for statistical models used for public reporting of health outcomes: an American Heart Association scientific statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group: cosponsored by the Council on Epidemiology and Prevention and the Stroke Council. Circulation. 2006;113:456-62.
13. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). J Am Coll Cardiol. 2006;47:e1-192.
14. Creager MA, White CJ, Hiatt WR, et al. Atherosclerotic Peripheral Vascular Disease Symposium II: executive summary. Circulation. 2008; 118:2811-25.
15. Hiatt WR, Goldstone J, Smith SC Jr., et al. Atherosclerotic Peripheral Vascular Disease Symposium II: nomenclature for vascular diseases. Circulation. 2008;118:2826-9.
16. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25-146.
17. Criqui MH, Fronek A, Barrett-Connor E, et al. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71:510-5.
18. Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudiation: the Framingham Study. J Am Geriatr Soc. 1985;33:13-8.
19. Regensteiner JG, Hiatt WR. Current medical therapies for patients with peripheral arterial disease: a critical review. Am J Med. 2002;112:49-57.
20. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317-24.
21. McDermott MM, Greenland P, Liu K, et al. The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med. 2002;136:873-83.
22. Barletta G, Perna S, Sabba C, et al. Quality of life in patients with intermittent claudication: relationship with laboratory exercise performance. Vasc Med. 1996;1:3-7.
23. Khaira HS, Hanger R, Shearman CP. Quality of life in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 1996;11: 65-9.
24. Pell JP. Impact of intermittent claudication on quality of life. The Scottish Vascular Audit Group. Eur J Vasc Endovasc Surg. 1995;9: 469-72.
25. Ponte E, Cattinelli S. Quality of life in a group of patients with intermittent claudication. Angiology. 1996;47:247-51.
26. Treat-Jacobson D, Halverson S, Ratchford A, et al. A patient-derived perspective of health-related quality-of-life in peripheral arterial disease. Journal of Nursing Scholarship. 2002;34:55-60.
27. Smolderen KG, Aquarius AE, de Vries J, et al. Depressive symptoms in peripheral arterial disease: a follow-up study on prevalence, stability, and risk factors. J Affect Disord. 2008;110:27-35.
28. Vogt MT, Cauley JA, Newman AB, et al. Decreased ankle/arm blood pressure index and mortality in elderly women. JAMA. 1993;270: 465-9.
29. McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis. 1991;87:119-28.
30. Newman AB, Shemanski L, Manolio TA, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1999;19:538-45.
31. Criqui MH, Coughlin SS, Fronek A. Noninvasively diagnosed peripheral arterial disease as a predictor of mortality: results from a prospective study. Circulation. 1985;72:768-73.
32. Newman AB, Tyrrell KS, Kuller LH. Mortality over four years in SHEP participants with a low ankle-arm index. J Am Geriatr Soc. 1997;45: 1472-8.
33. Resnick HE, Lindsay RS, McDermott MM, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation. 2004;109:733-9.
34. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-6.
35. Leng GC, Lee AJ, Fowkes FG, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1996;25: 1172-81.
36. Criqui MH, Denenberg JO, Langer RD, et al. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med. 1997;2:221-6.
37. Ness J, Aronow WS. Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice. J Am Geriatr Soc. 1999;47:1255-6.
38. Zheng ZJ, Sharrett AR, Chambless LE, et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 1997;131:115-25.
39. Burek KA, Sutton-Tyrrell K, Brooks MM, et al. Prognostic importance of lower extremity arterial disease in patients undergoing coronary revascu-larization in the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol. 1999;34:716-21.
40. Saw J, Bhatt DL, Moliterno DJ, et al. The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. J Am Coll Cardiol. 2006;48:1567-72.
41. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:1-75.
42. Normand SL, McNeil BJ, Peterson LE, et al. Eliciting expert opinion using the Delphi technique: identifying performance indicators for cardiovascular disease. Int J Qual Health Care. 1998;10:247-60.
43. Steg PG, Bhatt DL, Wilson PW, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297:1197-206.
44. Diehm C, Lange S, Darius H, et al. Association of low ankle brachial index with high mortality in primary care. Eur Heart J. 2006;27: 1743-9.
45. Selvin E, Hirsch AT. Contemporary risk factor control and walking dysfunction in individuals with peripheral arterial disease: NHANES 1999-2004. Atherosclerosis. 2008;201:425-33.
46. Feringa HH, van Waning VH, Bax JJ, et al. Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease. J Am Coll Cardiol. 2006;47:1182-7.
47. McDermott MM, Hahn EA, Greenland P, et al. Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey. J Gen Intern Med. 2002;17:895-904.
48. McDermott MM, Mandapat AL, Moates A, et al. Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease. Arch Intern Med. 2003;163: 2157-62.
49. Perlstein TS, Creager MA. The ankle-brachial index as a biomarker of cardiovascular risk: it's not just about the legs. Circulation. 2009;120:2033-5.
50. Fowkes FG, Murray GD, Butcher I, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300:197-208.
51. Berger JS, Krantz MJ, Kittelson JM, et al. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA. 2009;301:1909-19.
52. Fowkes FG, Price JF, Stewart MC, et al. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA. 2010;303 :841-8.
53. Hiatt WR. Medical treatment of peripheral arterial disease and claudica-tion. N Engl J Med. 2001;344:1608-21.
54. Stewart KJ, Hiatt WR, Regensteiner JG, et al. Exercise training for claudication. N Engl J Med. 2002;347:1941-51.
55. Bandyk DF, Schmitt DD, Seabrook GR, et al. Monitoring functional patency of in situ saphenous vein bypasses: the impact of a surveillance protocol and elective revision. J Vasc Surg. 1989;9:286-96.
56. Lundell A, Lindblad B, Bergqvist D, et al. Femoropopliteal-crural graft patency is improved by an intensive surveillance program: a prospective randomized study. J Vasc Surg. 1995;21:26-33.
57. Davies AH, Hawdon AJ, Sydes MR, et al. Is Duplex surveillance of value after leg vein bypass grafting? Principal results of the Vein Graft Surveillance Randomised Trial (VGST). Circulation. 2005;112:1985-91.
58. Cooper CJ, Murphy TP, Matsumoto A, et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J. 2006;152:59-66.
59. National Diabetes Quality Improvement Alliance. Performance measurement set for adult diabetes. Available at: http://www-nehc.med.navy.mil/bumed/ diabetes/document%20folders/diabetes/cpg/dqia.msrs.pdf. Accessed January 5, 2010.
60. National Quality Forum. National voluntary consensus standards for ambulatory care: diabetes care measures. Available at: http://www. qualityforum.org/Publications/2008/03/National-Voluntary-Consensus- Standards-for-Ambulatory-Care%E2%80%93Part-2.aspx. Accessed December 24, 2009.
61. Fleming C, Whitlock EP, Beil TL, et al. Screening for abdominal aortic aneurysm: a best-evidence systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2005;142:203-11.
62. Kent KC, Zwolak RM, Jaff MR, et al. Screening for abdominal aortic aneurysm: a consensus statement. J Vasc Surg. 2004;39:267-9.
63. Screening for abdominal aortic aneurysm: recommendation statement. Ann Intern Med. 2005;142:198-202.
64. Ashton HA, Gao L, Kim LG, et al. Fifteen-year follow-up of a randomized clinical trial of ultrasonographic screening for abdominal aortic aneurysms. Br J Surg. 2007;94:696-701.
65. Cosford PA, Leng GC. Screening for abdominal aortic aneurysm. Cochrane Database Syst Rev. 2007;CD002945.
66. Lindholt JS, Norman P. Screening for abdominal aortic aneurysm reduces overall mortality in men. A meta-analysis of the mid- and long-term effects of screening for abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2008;36:167-71.
67. Kim LG, Scott RAP, Ashton HA, et al. A sustained mortality benefit from screening for abdominal aortic aneurysm. Ann Intern Med. 2007;146: 699-706.
68. Olin JW. Long-term outcomes and cost-effectiveness of screening for abdominal aortic aneurysm. Nat Clin Pract Cardiovasc Med. 2007;4: 650-1.
69. MRC/BHF Heart Protection Study of cholesterol lowering with simva-statin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
70. Smith SC, Jr., Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. J Am Coll Cardiol. 2006;47:2130-9.
71. The Vascular Disease Foundation (VDF) and the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR). P.A.D. exercise training toolkit: a guide for health care professionals. Available at: http://www.vdf.org/professionals/exercisetoolkit.php. Accessed May 25, 2010.
72. American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription. 7th ed. Baltimore, Md: Lippincott Williams & Wilkins; 2006.
73. Penchansky R, Thomas JW. The concept of access: definition and relationship to consumer satisfaction. Med Care. 1981;19:127-40.